SMS PHARMACEUTICALS LTD. - 532815 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Thirumalesh TummaDesignation :- Company Secretary and Compliance Officer SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Credit Rating
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015. SMS PHARMACEUTICALS LTD. - 532815 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting results and Scrutinizer report of Annual General Meeting held on 30-Sep-2022 SMS PHARMACEUTICALS LTD. - 532815 - Closure of Trading Window
Intimation of closure of Trading Window SMS PHARMACEUTICALS LTD. - 532815 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of Annual General Meeting held on 30-Sep-2022 SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR), Regulations 2015. SMS PHARMACEUTICALS LTD. - 532815 - Revised Auditor''s Limited Review Report For The Consolidated Financials Results For The Quarter Ended 30Th June 2022
We are herewith submitting Revised Auditor''s Limited Review Report for the Consolidated Financials Results against the quarter ended 30th June 2022 SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement confirming dispatch of the Notice of the 34th Annual General Meeting SMS PHARMACEUTICALS LTD. - 532815 - Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2021-2022.